Skip to content

Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim

Minimal Risk Registry of Endoscopic Image and Pathology Correlation Using Fujifilm 7000 Blue Light Imaging System With 4 Light-emitting Diode (LED) Multi Light Technology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03440047
Enrollment
355
Registered
2018-02-20
Start date
2017-08-28
Completion date
2023-03-01
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro-Intestinal Disorder

Keywords

endoscopic image, Fujifilm, Blue light imaging

Brief summary

The purpose of this study is to see if advanced endoscopic imaging may be helpful to accurately distinguish pathological tissue from normal tissue and guide therapy of endoscopically identified pathology.

Detailed description

In this registry, the Fujifilm 4-LED system, which is considered non significant risk, will be used for routine endoscopic procedures at Mayo Clinic Florida and Rochester. Where indicated and based on clinical standards of care, a biopsy or tissue removal will be performed. Immediately prior to tissue removal, a standard set of electronic images will be captured including white light, BLI, BLI-bright, LCI. Each image will be stored in high resolution lossless format and later correlated with the final clinical and histological diagnosis.

Interventions

DEVICEFuji Flim Processor VP-7000, Light Source BL-7000

Fujifilm's Digital Video Processor VP-7000 and LED Light Source BL-7000 is a class II Endoscopic Video Imaging System under 21 C.F.R. 876.1500. It is the next generation of Fujifilm's VP-4440HD Digital Video Processor with Flexible-spectral Imaging Color Enhancement (FICE) and Light Source (K140149).

Sponsors

Fujifilm Medical Systems USA, Inc.
CollaboratorINDUSTRY
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Registry of endoscopic image and pathology correlation of different pathological condition such as: inflammatory bowel disease, colon polyps

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. All patients age 18-100 undergoing planned upper or lower endoscopy at Mayo Clinic Rochester 2. Informed Consent

Exclusion criteria

1\. Patient unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological DiagnosisApproximately one yearSubjects presenting with gastrointestinal mucosal disorders will have a biopsy based on clinical standard of care. Just prior to the biopsy, a standard set of electronic images will be captured using the Fujifilm 7000 Blue Light Imaging System with 4-LED Multi Light Technology. Images will be correlated with the final clinical and histological diagnosis of the gastrointestinal disorder.

Countries

United States

Participant flow

Participants by arm

ArmCount
Fuji Film Processor VP-7000
Screening or surveillance endoscopy using Fuji Flim Processor VP-7000, Light Source BL-7000 Fuji Flim Processor VP-7000, Light Source BL-7000: Fujifilm's Digital Video Processor VP-7000 and LED Light Source BL-7000 is a class II Endoscopic Video Imaging System under 21 C.F.R. 876.1500. It is the next generation of Fujifilm's VP-4440HD Digital Video Processor with Flexible-spectral Imaging Color Enhancement (FICE) and Light Source (K140149).
355
Total355

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicFuji Film Processor VP-7000
Age, Continuous59.7 years
Ethnicity (NIH/OMB)
Hispanic or Latino
14 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
336 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
14 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
7 Participants
Race (NIH/OMB)
White
325 Participants
Region of Enrollment
United States
355 Participants
Sex: Female, Male
Female
154 Participants
Sex: Female, Male
Male
201 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 355
other
Total, other adverse events
13 / 355
serious
Total, serious adverse events
4 / 355

Outcome results

Primary

Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis

Subjects presenting with gastrointestinal mucosal disorders will have a biopsy based on clinical standard of care. Just prior to the biopsy, a standard set of electronic images will be captured using the Fujifilm 7000 Blue Light Imaging System with 4-LED Multi Light Technology. Images will be correlated with the final clinical and histological diagnosis of the gastrointestinal disorder.

Time frame: Approximately one year

Population: Participants with available histopathological \[or other clinical results\] to correlate with the images collected endoscopically

ArmMeasureValue (NUMBER)
Fuji Film Processor VP-7000Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis283 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026